Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Relapsed/refractory Diffuse Large B-Cell Lymphoma. Strongest funded area: Gene Therapy / Cell Therapy. Largest gap: Clinical Research.
Clinical ResearchTrials Active, No NIH Grants
23 clinical trials registered but no NIH-funded clinical or translational research grants found for relapsed/refractory diffuse large B-cell lymphoma. Trials may be industry-sponsored or funded through non-NIH sources.
Biomarker / DiagnosticsPublished, Not NIH-Funded
12 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for relapsed/refractory diffuse large B-cell lymphoma. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
22 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for relapsed/refractory diffuse large B-cell lymphoma. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
68 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for relapsed/refractory diffuse large B-cell lymphoma. Existing research activity suggests this may be a viable area for grant applications.
Basic SciencePublished, Not NIH-Funded
17 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for relapsed/refractory diffuse large B-cell lymphoma. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
18 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for relapsed/refractory diffuse large B-cell lymphoma. Existing research activity suggests this may be a viable area for grant applications.
Top Funded Institutions
1
AVM BIOTECHNOLOGY, LLC$992K
WA1 grantDeisher, Theresa
Top Principal Investigators
1
Deisher, Theresa$992K
AVM BIOTECHNOLOGY, LLC·1 grant
Gene/Cell Therapy
NIH Grants & Funding for Relapsed/refractory Diffuse Large B-Cell Lymphoma | Kisho | Kisho
